Pharma Industry News

Gilead’s EVP of R&D and chief scientific officer to step down

Norbert Bischofberger, who has been with the company since 1990, will be replaced by current EVP of clinical research John McHutchisonOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]